

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.51724039 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.45299456 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.24046909 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.07498728 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.39761649 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.39761649 |
| 7 | positive regulation of granulocyte differentiation (GO:0030854) | 4.38037596 |
| 8 | negative thymic T cell selection (GO:0045060) | 4.33023623 |
| 9 | negative T cell selection (GO:0043383) | 4.31855508 |
| 10 | positive regulation of histone deacetylation (GO:0031065) | 4.26718020 |
| 11 | positive regulation of CREB transcription factor activity (GO:0032793) | 4.15663884 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.11053333 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.10862383 |
| 14 | T cell selection (GO:0045058) | 4.08881341 |
| 15 | histone H3-K36 demethylation (GO:0070544) | 4.08338326 |
| 16 | positive T cell selection (GO:0043368) | 4.00645993 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.90415097 |
| 18 | thymic T cell selection (GO:0045061) | 3.88267118 |
| 19 | positive thymic T cell selection (GO:0045059) | 3.86617712 |
| 20 | tolerance induction (GO:0002507) | 3.69764167 |
| 21 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.67342701 |
| 22 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.64972155 |
| 23 | B cell receptor signaling pathway (GO:0050853) | 3.60083443 |
| 24 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.59165504 |
| 25 | activated T cell proliferation (GO:0050798) | 3.52023368 |
| 26 | NIK/NF-kappaB signaling (GO:0038061) | 3.51967478 |
| 27 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.50558416 |
| 28 | positive regulation of protein deacetylation (GO:0090312) | 3.48625230 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.47879399 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.42465292 |
| 31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.40536601 |
| 32 | response to interleukin-15 (GO:0070672) | 3.40249802 |
| 33 | negative regulation of histone acetylation (GO:0035067) | 3.38241412 |
| 34 | regulation of granulocyte differentiation (GO:0030852) | 3.38187292 |
| 35 | natural killer cell differentiation (GO:0001779) | 3.33883307 |
| 36 | leukocyte aggregation (GO:0070486) | 3.29443812 |
| 37 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.29298067 |
| 38 | mannose metabolic process (GO:0006013) | 3.24491697 |
| 39 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.21173160 |
| 40 | cellular response to interleukin-15 (GO:0071350) | 3.20485836 |
| 41 | response to muramyl dipeptide (GO:0032495) | 3.20284686 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.17952572 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 3.17952572 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.17952572 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.17952572 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.17952572 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.17952572 |
| 48 | regulation of histone H3-K27 methylation (GO:0061085) | 3.15507926 |
| 49 | regulation of B cell differentiation (GO:0045577) | 3.07948868 |
| 50 | germinal center formation (GO:0002467) | 3.03071203 |
| 51 | regulation of histone deacetylation (GO:0031063) | 3.01806027 |
| 52 | histone H3 deacetylation (GO:0070932) | 3.00193064 |
| 53 | Peyers patch development (GO:0048541) | 3.00049896 |
| 54 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.00049896 |
| 55 | T cell migration (GO:0072678) | 2.97253157 |
| 56 | positive regulation of antigen processing and presentation (GO:0002579) | 2.93539415 |
| 57 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.90255368 |
| 58 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87979839 |
| 59 | histone H3-K9 modification (GO:0061647) | 2.86926821 |
| 60 | histone H4 deacetylation (GO:0070933) | 2.82169478 |
| 61 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.80814788 |
| 62 | positive regulation of B cell differentiation (GO:0045579) | 2.79467413 |
| 63 | T cell homeostasis (GO:0043029) | 2.79397852 |
| 64 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.77887357 |
| 65 | negative regulation of phagocytosis (GO:0050765) | 2.74036519 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72701328 |
| 67 | regulation of defense response to virus by host (GO:0050691) | 2.72459036 |
| 68 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.71337843 |
| 69 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.70911740 |
| 70 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.69754200 |
| 71 | negative regulation of cell size (GO:0045792) | 2.69002436 |
| 72 | histone H3-K9 methylation (GO:0051567) | 2.67605716 |
| 73 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.67597159 |
| 74 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.65845216 |
| 75 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.63248178 |
| 76 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.62565842 |
| 77 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.61373489 |
| 78 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.61373489 |
| 79 | detection of bacterium (GO:0016045) | 2.59464463 |
| 80 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.58834254 |
| 81 | histone H3-K4 trimethylation (GO:0080182) | 2.55880329 |
| 82 | snRNA processing (GO:0016180) | 2.55825204 |
| 83 | snRNA metabolic process (GO:0016073) | 2.54926552 |
| 84 | response to type I interferon (GO:0034340) | 2.54541121 |
| 85 | lymphocyte homeostasis (GO:0002260) | 2.52708325 |
| 86 | negative regulation of interleukin-12 production (GO:0032695) | 2.52510671 |
| 87 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.52174436 |
| 88 | regulation of natural killer cell differentiation (GO:0032823) | 2.51793563 |
| 89 | negative regulation of interleukin-6 production (GO:0032715) | 2.51511561 |
| 90 | regulation of antigen processing and presentation (GO:0002577) | 2.50598302 |
| 91 | mitochondrion distribution (GO:0048311) | 2.49957734 |
| 92 | negative regulation of interleukin-1 production (GO:0032692) | 2.47017176 |
| 93 | negative regulation of viral release from host cell (GO:1902187) | 2.47007838 |
| 94 | B cell homeostasis (GO:0001782) | 2.44952384 |
| 95 | Rap protein signal transduction (GO:0032486) | 2.44342855 |
| 96 | cellular response to type I interferon (GO:0071357) | 2.43530568 |
| 97 | type I interferon signaling pathway (GO:0060337) | 2.43530568 |
| 98 | negative regulation of protein oligomerization (GO:0032460) | 2.43303372 |
| 99 | T cell receptor signaling pathway (GO:0050852) | 2.42724732 |
| 100 | detection of other organism (GO:0098543) | 2.42543814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.36330185 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.23961489 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.09861514 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.29707791 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.85499061 |
| 6 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.72490797 |
| 7 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.65966579 |
| 8 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.62053455 |
| 9 | MAF_26560356_Chip-Seq_TH1_Human | 2.61595406 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.58466374 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.53417415 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.50997707 |
| 13 | UTX_26944678_Chip-Seq_JUKART_Human | 2.50050925 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.49876971 |
| 15 | MAF_26560356_Chip-Seq_TH2_Human | 2.41086830 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.38381614 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.29489583 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.28333481 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.15912556 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.09733838 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.08731682 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05507058 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04597773 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99760858 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.98972194 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.98029975 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93700953 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92371375 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.92088580 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85779994 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.85415976 |
| 32 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.85094075 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.85093207 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.83236912 |
| 35 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.82916842 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78561307 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76495626 |
| 38 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.71087189 |
| 39 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.68928191 |
| 40 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68242725 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67120696 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66389260 |
| 43 | P68_20966046_ChIP-Seq_HELA_Human | 1.63184060 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.62288720 |
| 45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.61628691 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.58555869 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55924486 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52255767 |
| 49 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.51894769 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48348447 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46796117 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46034271 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44922106 |
| 54 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.43539190 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41384139 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35028105 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34591523 |
| 58 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.33892370 |
| 59 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.33600529 |
| 60 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.32707432 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32410605 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32060730 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31043031 |
| 64 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.30088950 |
| 65 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29690507 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27586917 |
| 67 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.26491607 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22257303 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22093478 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21882686 |
| 71 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.17715599 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17216211 |
| 73 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14935609 |
| 74 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14644069 |
| 75 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.14532644 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14082874 |
| 77 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.13687335 |
| 78 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.13686305 |
| 79 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13463498 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12993149 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11578568 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11331364 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08717106 |
| 84 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08394556 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07302337 |
| 86 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07152181 |
| 87 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06630303 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06273942 |
| 89 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.03707118 |
| 90 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01780601 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01102245 |
| 92 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.00605482 |
| 93 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99956208 |
| 94 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98869784 |
| 95 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98374457 |
| 96 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.98350965 |
| 97 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.98315732 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98312694 |
| 99 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98084389 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97865060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.74966253 |
| 2 | MP0003172_abnormal_lysosome_physiology | 3.14085932 |
| 3 | MP0003436_decreased_susceptibility_to | 3.12018438 |
| 4 | MP0001800_abnormal_humoral_immune | 2.99734427 |
| 5 | MP0000685_abnormal_immune_system | 2.90228122 |
| 6 | MP0005671_abnormal_response_to | 2.78272211 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.59056673 |
| 8 | MP0001873_stomach_inflammation | 2.55978233 |
| 9 | MP0005387_immune_system_phenotype | 2.48282220 |
| 10 | MP0001790_abnormal_immune_system | 2.48282220 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.45845897 |
| 12 | MP0004381_abnormal_hair_follicle | 2.45677152 |
| 13 | MP0002723_abnormal_immune_serum | 2.44914591 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.44572328 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.34332124 |
| 16 | MP0000703_abnormal_thymus_morphology | 2.31893222 |
| 17 | MP0001819_abnormal_immune_cell | 2.31233704 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.29782019 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.26834539 |
| 20 | MP0005076_abnormal_cell_differentiation | 2.25551210 |
| 21 | MP0001348_abnormal_lacrimal_gland | 2.20626387 |
| 22 | MP0002398_abnormal_bone_marrow | 2.17529635 |
| 23 | MP0005310_abnormal_salivary_gland | 2.15762914 |
| 24 | MP0003303_peritoneal_inflammation | 2.14941290 |
| 25 | MP0005025_abnormal_response_to | 2.07113086 |
| 26 | MP0002419_abnormal_innate_immunity | 2.04102794 |
| 27 | MP0000716_abnormal_immune_system | 1.95765437 |
| 28 | MP0001849_ear_inflammation | 1.93643021 |
| 29 | MP0009278_abnormal_bone_marrow | 1.85103295 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.84064351 |
| 31 | MP0002722_abnormal_immune_system | 1.79901693 |
| 32 | MP0002405_respiratory_system_inflammati | 1.71213493 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.70685881 |
| 34 | MP0009785_altered_susceptibility_to | 1.68038587 |
| 35 | MP0002429_abnormal_blood_cell | 1.62013842 |
| 36 | MP0003724_increased_susceptibility_to | 1.60653719 |
| 37 | MP0002933_joint_inflammation | 1.51186136 |
| 38 | MP0008260_abnormal_autophagy | 1.48266563 |
| 39 | MP0002254_reproductive_system_inflammat | 1.44948578 |
| 40 | MP0002009_preneoplasia | 1.42631774 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.39406559 |
| 42 | MP0005451_abnormal_body_composition | 1.39332460 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.36979203 |
| 44 | MP0008877_abnormal_DNA_methylation | 1.35741240 |
| 45 | MP0003943_abnormal_hepatobiliary_system | 1.35342488 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.31826851 |
| 47 | MP0009840_abnormal_foam_cell | 1.30008926 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.29923402 |
| 49 | MP0000371_diluted_coat_color | 1.29352450 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.28157095 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.28157095 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.27660787 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.25540524 |
| 54 | MP0006082_CNS_inflammation | 1.20623568 |
| 55 | MP0008961_abnormal_basal_metabolism | 1.16445877 |
| 56 | MP0003045_fibrosis | 1.14726651 |
| 57 | MP0003866_abnormal_defecation | 1.13025797 |
| 58 | MP0004947_skin_inflammation | 1.12875936 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.10590243 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.08300820 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.04935838 |
| 62 | MP0002693_abnormal_pancreas_physiology | 1.04431609 |
| 63 | MP0001851_eye_inflammation | 0.99889917 |
| 64 | MP0005058_abnormal_lysosome_morphology | 0.97676919 |
| 65 | MP0002970_abnormal_white_adipose | 0.97527929 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 0.93404919 |
| 67 | MP0008995_early_reproductive_senescence | 0.89705350 |
| 68 | MP0001663_abnormal_digestive_system | 0.89635702 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.88941945 |
| 70 | MP0008469_abnormal_protein_level | 0.88261790 |
| 71 | MP0002168_other_aberrant_phenotype | 0.87991807 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.87862694 |
| 73 | MP0000733_abnormal_muscle_development | 0.85291875 |
| 74 | MP0003828_pulmonary_edema | 0.85023029 |
| 75 | MP0002166_altered_tumor_susceptibility | 0.82648831 |
| 76 | MP0002075_abnormal_coat/hair_pigmentati | 0.82429256 |
| 77 | MP0000538_abnormal_urinary_bladder | 0.81787239 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 0.78091361 |
| 79 | MP0002998_abnormal_bone_remodeling | 0.77618160 |
| 80 | MP0005367_renal/urinary_system_phenotyp | 0.77505117 |
| 81 | MP0000516_abnormal_urinary_system | 0.77505117 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74908236 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 0.72007773 |
| 84 | MP0001661_extended_life_span | 0.71198539 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.70408711 |
| 86 | MP0001853_heart_inflammation | 0.70229259 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.66065112 |
| 88 | MP0009764_decreased_sensitivity_to | 0.65918146 |
| 89 | MP0002132_abnormal_respiratory_system | 0.64813191 |
| 90 | MP0000470_abnormal_stomach_morphology | 0.64635585 |
| 91 | MP0000490_abnormal_crypts_of | 0.63530781 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.59628183 |
| 93 | MP0003329_amyloid_beta_deposits | 0.59047322 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.58800736 |
| 95 | MP0005448_abnormal_energy_balance | 0.58033313 |
| 96 | MP0005360_urolithiasis | 0.56909473 |
| 97 | MP0000249_abnormal_blood_vessel | 0.55145675 |
| 98 | MP0000604_amyloidosis | 0.53739158 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.53628740 |
| 100 | MP0010307_abnormal_tumor_latency | 0.52513263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asymmetry of the thorax (HP:0001555) | 4.07971147 |
| 2 | Recurrent fungal infections (HP:0002841) | 3.80006567 |
| 3 | Panhypogammaglobulinemia (HP:0003139) | 3.68818792 |
| 4 | Recurrent cutaneous fungal infections (HP:0011370) | 3.57356250 |
| 5 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.57356250 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.52877222 |
| 7 | Agammaglobulinemia (HP:0004432) | 3.51936741 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.30606395 |
| 9 | J-shaped sella turcica (HP:0002680) | 3.08409550 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 3.07951656 |
| 11 | Thoracic kyphosis (HP:0002942) | 3.01833837 |
| 12 | Long foot (HP:0001833) | 2.93249045 |
| 13 | Recurrent viral infections (HP:0004429) | 2.85806560 |
| 14 | Pustule (HP:0200039) | 2.84943520 |
| 15 | Stomatitis (HP:0010280) | 2.84709742 |
| 16 | T lymphocytopenia (HP:0005403) | 2.76499263 |
| 17 | Meningitis (HP:0001287) | 2.74866383 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 2.72119793 |
| 19 | Hyperventilation (HP:0002883) | 2.68890332 |
| 20 | Urethral obstruction (HP:0000796) | 2.56808885 |
| 21 | Papilloma (HP:0012740) | 2.56262216 |
| 22 | Verrucae (HP:0200043) | 2.56262216 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52893052 |
| 24 | Recurrent skin infections (HP:0001581) | 2.49343568 |
| 25 | Abnormality of T cell number (HP:0011839) | 2.48234699 |
| 26 | Anal stenosis (HP:0002025) | 2.48104328 |
| 27 | Recurrent abscess formation (HP:0002722) | 2.47690468 |
| 28 | Abnormality of the fingertips (HP:0001211) | 2.46283232 |
| 29 | Abnormality of the thoracic spine (HP:0100711) | 2.45560376 |
| 30 | Dysostosis multiplex (HP:0000943) | 2.44692169 |
| 31 | Abnormality of T cells (HP:0002843) | 2.43842744 |
| 32 | Increased IgE level (HP:0003212) | 2.40460599 |
| 33 | Tented upper lip vermilion (HP:0010804) | 2.30441985 |
| 34 | Cellulitis (HP:0100658) | 2.29240788 |
| 35 | Abnormality of the lumbar spine (HP:0100712) | 2.28798977 |
| 36 | Chest pain (HP:0100749) | 2.27922550 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.27334360 |
| 38 | Lymphopenia (HP:0001888) | 2.24461650 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 2.21643339 |
| 40 | Clumsiness (HP:0002312) | 2.21353297 |
| 41 | Enlarged penis (HP:0000040) | 2.21264812 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20482392 |
| 43 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20482392 |
| 44 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20482392 |
| 45 | Lymphangioma (HP:0100764) | 2.19749065 |
| 46 | Encephalitis (HP:0002383) | 2.18984967 |
| 47 | Hypoplasia of the thymus (HP:0000778) | 2.18400027 |
| 48 | Birth length less than 3rd percentile (HP:0003561) | 2.18126424 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16799577 |
| 50 | Combined immunodeficiency (HP:0005387) | 2.16460464 |
| 51 | Myositis (HP:0100614) | 2.15587008 |
| 52 | Broad face (HP:0000283) | 2.11509236 |
| 53 | Increased cerebral lipofuscin (HP:0011813) | 2.11150954 |
| 54 | Colitis (HP:0002583) | 2.04764686 |
| 55 | Germ cell neoplasia (HP:0100728) | 2.03640731 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01386810 |
| 57 | Partial agenesis of the corpus callosum (HP:0001338) | 2.00031221 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99403817 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99403817 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99403817 |
| 61 | Granulocytopenia (HP:0001913) | 1.98148534 |
| 62 | Protruding tongue (HP:0010808) | 1.96446719 |
| 63 | Hemoptysis (HP:0002105) | 1.95565965 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 1.95245328 |
| 65 | Gingivitis (HP:0000230) | 1.93854850 |
| 66 | Elfin facies (HP:0004428) | 1.91981155 |
| 67 | Mesangial abnormality (HP:0001966) | 1.90620994 |
| 68 | Neoplasm of the adrenal cortex (HP:0100641) | 1.89920759 |
| 69 | Viral hepatitis (HP:0006562) | 1.88195343 |
| 70 | Breast hypoplasia (HP:0003187) | 1.87036729 |
| 71 | Neurodegeneration (HP:0002180) | 1.84298967 |
| 72 | Inflammation of the large intestine (HP:0002037) | 1.83762974 |
| 73 | Amelogenesis imperfecta (HP:0000705) | 1.82325621 |
| 74 | Hyperacusis (HP:0010780) | 1.81060510 |
| 75 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.80972140 |
| 76 | Abnormality of macrophages (HP:0004311) | 1.80742272 |
| 77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.80700938 |
| 78 | Widely spaced teeth (HP:0000687) | 1.80696962 |
| 79 | Hypochromic anemia (HP:0001931) | 1.80673774 |
| 80 | Fatigue (HP:0012378) | 1.78611842 |
| 81 | Thyroiditis (HP:0100646) | 1.77984312 |
| 82 | Microtia (HP:0008551) | 1.76469704 |
| 83 | Acute lymphatic leukemia (HP:0006721) | 1.76241633 |
| 84 | Leukocytosis (HP:0001974) | 1.75983145 |
| 85 | Recurrent pneumonia (HP:0006532) | 1.74952158 |
| 86 | Abnormality of eosinophils (HP:0001879) | 1.74439530 |
| 87 | IgG deficiency (HP:0004315) | 1.74370426 |
| 88 | Vasculitis (HP:0002633) | 1.74111142 |
| 89 | Sepsis (HP:0100806) | 1.72977299 |
| 90 | Mucopolysacchariduria (HP:0008155) | 1.72404378 |
| 91 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72404378 |
| 92 | Neoplasm of the heart (HP:0100544) | 1.70400298 |
| 93 | Concave nail (HP:0001598) | 1.69624845 |
| 94 | Restrictive lung disease (HP:0002091) | 1.69580421 |
| 95 | Basal cell carcinoma (HP:0002671) | 1.69274086 |
| 96 | Orchitis (HP:0100796) | 1.67716557 |
| 97 | Optic neuritis (HP:0100653) | 1.67691152 |
| 98 | Retrobulbar optic neuritis (HP:0100654) | 1.67691152 |
| 99 | Hamartoma of the eye (HP:0010568) | 1.66588841 |
| 100 | Stridor (HP:0010307) | 1.65603979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.07812182 |
| 2 | MAP4K1 | 3.80969368 |
| 3 | TRIB3 | 3.78424321 |
| 4 | SIK2 | 2.79922937 |
| 5 | SIK3 | 2.65329851 |
| 6 | TYK2 | 2.40630295 |
| 7 | TNK2 | 2.32466521 |
| 8 | SMG1 | 2.04957976 |
| 9 | FES | 2.00609503 |
| 10 | TXK | 1.99590230 |
| 11 | PRPF4B | 1.99043015 |
| 12 | MAP3K10 | 1.92676053 |
| 13 | ACVR1B | 1.81192745 |
| 14 | ZAP70 | 1.76982668 |
| 15 | SIK1 | 1.76403491 |
| 16 | IKBKE | 1.62544157 |
| 17 | BLK | 1.60183728 |
| 18 | IRAK4 | 1.57790710 |
| 19 | EEF2K | 1.55510054 |
| 20 | MAP3K14 | 1.54774828 |
| 21 | CAMKK1 | 1.50990744 |
| 22 | BTK | 1.49556477 |
| 23 | GRK6 | 1.46794183 |
| 24 | PRKD2 | 1.42584910 |
| 25 | HIPK2 | 1.41760408 |
| 26 | ITK | 1.38820688 |
| 27 | MAP3K7 | 1.37793977 |
| 28 | IKBKB | 1.36517333 |
| 29 | RIPK4 | 1.33433460 |
| 30 | JAK3 | 1.32983258 |
| 31 | ERN1 | 1.28415596 |
| 32 | HCK | 1.27113078 |
| 33 | MAPK12 | 1.25812317 |
| 34 | EPHB1 | 1.23133474 |
| 35 | MARK2 | 1.20750883 |
| 36 | NME1 | 1.20632048 |
| 37 | SYK | 1.12568172 |
| 38 | PKN2 | 1.11898759 |
| 39 | TBK1 | 1.07894923 |
| 40 | MAP3K13 | 1.06918013 |
| 41 | LYN | 1.05934607 |
| 42 | MAP2K3 | 1.03812122 |
| 43 | CSF1R | 1.02101759 |
| 44 | MAPK13 | 1.01909953 |
| 45 | LCK | 1.01535316 |
| 46 | PASK | 1.01488667 |
| 47 | ICK | 1.00534071 |
| 48 | CSK | 0.94436175 |
| 49 | STK11 | 0.94084877 |
| 50 | KIT | 0.92456079 |
| 51 | MARK3 | 0.91950037 |
| 52 | FGR | 0.87060885 |
| 53 | PRKD3 | 0.86976931 |
| 54 | PTK2B | 0.81673689 |
| 55 | TAOK1 | 0.80598525 |
| 56 | MELK | 0.79270476 |
| 57 | CHUK | 0.79001450 |
| 58 | JAK1 | 0.77890780 |
| 59 | MAPK11 | 0.77473565 |
| 60 | CDK4 | 0.77401313 |
| 61 | FGFR4 | 0.75505038 |
| 62 | FGFR3 | 0.73085629 |
| 63 | PDK1 | 0.72656287 |
| 64 | MAPK7 | 0.72447945 |
| 65 | CDC42BPA | 0.71836876 |
| 66 | PTK6 | 0.70858988 |
| 67 | BRD4 | 0.70502735 |
| 68 | DAPK2 | 0.68600438 |
| 69 | TAOK3 | 0.68024335 |
| 70 | MAP3K1 | 0.67253666 |
| 71 | IRAK3 | 0.66627316 |
| 72 | IRAK2 | 0.63175062 |
| 73 | RPS6KA6 | 0.62170714 |
| 74 | IRAK1 | 0.60879173 |
| 75 | TGFBR1 | 0.60798313 |
| 76 | JAK2 | 0.60450126 |
| 77 | MAP2K6 | 0.59759375 |
| 78 | PIM1 | 0.58948037 |
| 79 | CDK12 | 0.58724913 |
| 80 | FRK | 0.55943392 |
| 81 | BMPR1B | 0.55885797 |
| 82 | CAMKK2 | 0.52494953 |
| 83 | MAPK8 | 0.50158707 |
| 84 | RPS6KC1 | 0.48776107 |
| 85 | RPS6KL1 | 0.48776107 |
| 86 | MTOR | 0.47471020 |
| 87 | TEC | 0.47352221 |
| 88 | CAMK4 | 0.47034352 |
| 89 | PDPK1 | 0.44525303 |
| 90 | EPHA3 | 0.43510489 |
| 91 | PKN1 | 0.43383243 |
| 92 | MAP3K3 | 0.42253153 |
| 93 | KSR2 | 0.41430623 |
| 94 | FER | 0.37691165 |
| 95 | NLK | 0.36912111 |
| 96 | TYRO3 | 0.36651904 |
| 97 | BMX | 0.35945178 |
| 98 | PRKCH | 0.35554359 |
| 99 | PRKD1 | 0.33839527 |
| 100 | MAP2K1 | 0.33734089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.19298404 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21042624 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.05406877 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.02642102 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.01119878 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98745114 |
| 7 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.83777888 |
| 8 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.74757598 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68992440 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.63276339 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.60634446 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.59635556 |
| 13 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.55282500 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.54249278 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.51681380 |
| 16 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.48826440 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47933096 |
| 18 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.40516603 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39993814 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34721472 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.34585985 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.34533105 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33548795 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.29478670 |
| 25 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.27755543 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22837813 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21359659 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20933874 |
| 29 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19420835 |
| 30 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19298419 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19270895 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18155744 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17562677 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17012893 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16677983 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.16189178 |
| 37 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.15795373 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.14728767 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.14556959 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.09838229 |
| 41 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.08156441 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04890172 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.04268497 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01047879 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98738897 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 0.98515253 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 0.97829913 |
| 48 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.96298874 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 0.94779224 |
| 50 | Colorectal cancer_Homo sapiens_hsa05210 | 0.94622459 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92468870 |
| 52 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91613716 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91541249 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90149474 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89688161 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85573014 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85534322 |
| 58 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85530310 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85191804 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84625272 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84291844 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.82950315 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82664946 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82624377 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.82060106 |
| 66 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.80265000 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.79990309 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79626756 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79104817 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78873248 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.78831491 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77671130 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77623413 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77067177 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75908126 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69686116 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69004602 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66775590 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65268710 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65118446 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64776360 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64232409 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.64202894 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.64082286 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63273820 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63198903 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61604565 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.61500767 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61451279 |
| 90 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61110878 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60615882 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60549931 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60144143 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59851550 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57028193 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.56829130 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.55777269 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54434405 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.53561536 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51228614 |

